NYSE ARCA | ETF
The fund is an actively managed exchange-traded fund.
The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries.
The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| PAGP | Plains GP Holdings LP | Energy | Oil & Gas Midstream | 36.62% |
| AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 14.95% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 10.59% |
| ARDX | Ardelyx Inc | Healthcare | Biotechnology | 8.31% |
| TCRX | Tscan Therapeutics Inc | Healthcare | Biotechnology | 7.56% |
| RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 5.10% |
| PHAT | Phathom Pharmaceuticals Inc | Healthcare | Biotechnology | 5.02% |
| CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 4.48% |
| TSAT | Telesat Corp | Technology | Communication Equipment | 3.71% |
| FULC | Fulcrum Therapeutics Inc | Healthcare | Biotechnology | 3.70% |
| APLT | Applied Therapeutics Inc | Healthcare | Biotechnology | 3.04% |
| TCRX_old | TCRX | Healthcare | Biotechnology | 2.93% |
| PCJ | ABEONA THERAPEUT. DL-01 | Healthcare | Biotechnology | 2.85% |
| DAWN | Day One Biopharmaceuticals Inc | Healthcare | Biotechnology | 2.76% |
| HIGH | Simplify Exchange Traded Funds - Simplify Enhanced Income ETF | 2.65% | ||
| SNDX | Syndax Pharmaceuticals Inc | Healthcare | Biotechnology | 2.50% |
| TSAT | Telesat Corp | Technology | Communication Equipment | 2.26% |
| MAAT | Maat Pharma SA | Healthcare | Biotechnology | 1.71% |
| KMPH | KemPharm Inc | Healthcare | Pharmaceuticals | 1.28% |
| KYMR | Kymera Therapeutics Inc | Healthcare | Biotechnology | 1.27% |